Translational Stem-Cell Research: Potential New Treatment for Blood Disorders Now in Clinical Trial

Dr. Catriona M. H. Jamieson and colleagues are performing the first clinical trial of a promising new treatment that was identified in the laboratory only last year.

The treatment may offer new hope to individuals who have myeloproliferative disorders (MPDs). MPDs can evolve into leukemia.

Catriona M. H. Jamieson, M.D., Ph.D., is Director for Stem Cell Research at the Moores UCSD Cancer Center. She is Assistant Professor of Medicine in the Division of Hematology-Oncology.

The findings that led to the clinical trial were published in Cancer Cell in April 2008. Read the report

Read the full story from UC San Diego Health Sciences Communications

More Information: